When it comes to long-term weight management, choosing between bariatric surgery and prescription weight-loss medicines can be challenging. Bariatric surgery, semaglutide-based medicines, and Tirzepatide-based medicines work in different ways and may offer different outcomes for people with obesity.

This guide compares weight loss surgery with medicines such as Ozempic (semaglutide) and Mounjaro (Tirzepatide), including how they work, potential benefits and risks, weight regain, and long-term treatment considerations.

Understanding these differences can help patients discuss the most appropriate treatment approach with a qualified obesity or bariatric specialist in Dubai.

Understanding Weight Loss Surgery in Dubai

Weight loss surgery in Dubai, also known as bariatric or metabolic surgery, is a medical treatment for obesity that helps achieve significant and sustained weight loss by changing the size of the stomach and, in some procedures, the digestive system.

Common procedures include sleeve gastrectomy and gastric bypass. The choice of procedure depends on factors such as BMI, existing health conditions, previous weight-loss attempts, and individual health goals.

The key features and potential benefits of bariatric surgery include:

  • Sleeve gastrectomy: Reduces the size of the stomach, helping control food intake and appetite.
  • Gastric bypass: Creates a smaller stomach pouch and changes the digestive pathway to support weight loss.
  • Health benefits: Bariatric surgery may also help improve obesity-related conditions such as type 2 diabetes, high blood pressure and sleep apnoea.
  • Long-term support: Regular medical follow-up, healthy eating and lifestyle changes are important after surgery.
  • Personalised treatment: A bariatric specialist can recommend the most suitable procedure based on your health and weight-loss needs.

Unlike a short-term weight-loss solution, bariatric surgery is part of a long-term approach to managing obesity and improving overall health.

Ozempic & Mounjaro: How Do They Work?

Ozempic and Mounjaro are prescription injectable medicines that are primarily used to manage type 2 diabetes. Their active ingredients, semaglutide and Tirzepatide, respectively, also have important effects on appetite, food intake and body weight.

For obesity treatment, semaglutide is available under the brand name Wegovy, while Tirzepatide is available under the brand name Zepbound in markets where these indications are approved. The appropriate medicine depends on the patient’s medical history, treatment goals and regulatory availability.

Ozempic

Ozempic contains semaglutide, a GLP-1 receptor agonist used primarily to improve blood sugar control in adults with type 2 diabetes. Semaglutide also reduces appetite and can increase feelings of fullness, which may contribute to weight loss.

 

Key points include:

  • Acts on the GLP-1 pathway
  • Helps regulate blood glucose levels
  • Can reduce appetite and food intake
  • Is generally administered once weekly
  • May cause gastrointestinal side effects such as nausea, vomiting, diarrhoea or constipation
  • Requires medical supervision and appropriate dose adjustment

Semaglutide is also available as Wegovy for chronic weight management in eligible patients.

Mounjaro

Mounjaro contains Tirzepatide, which acts on both GIP and GLP-1 receptors. It is primarily used to improve blood sugar control in adults with type 2 diabetes and can also reduce appetite and food intake.

Key points include:

  • Acts on both GIP and GLP-1 pathways
  • Can reduce hunger and increase feelings of fullness
  • Is generally administered once weekly
  • May cause gastrointestinal side effects
  • Requires medical supervision and gradual dose adjustment

Tirzepatide is also available as Zepbound for chronic weight management in eligible patients.

For patients considering prescription weight-management medicines in Dubai, a medical consultation can help determine whether medication is appropriate based on BMI, existing health conditions, treatment goals, previous treatment attempts and overall medical history. 

Weight Loss Surgery vs Ozempic & Mounjaro 

Weight loss surgery and prescription weight-management medicines can all play a role in obesity treatment, but they differ in how they work, treatment duration, recovery and long-term management. 

Factor 

Weight Loss Surgery 

Semaglutide-Based Treatment

Tirzepatide-Based Treatment 

Treatment 

Bariatric surgery 

Injectable medicine 

Injectable medicine 

How it works 

Changes stomach size and/or digestive anatomy, depending on the procedure  

Acts primarily through the GLP-1 pathway 

Acts through both GIP and GLP-1 pathways 

Weight loss 

Can produce substantial weight loss 

Can produce significant weight loss in eligible patients  

Can produce significant weight loss in eligible patients 

Surgery 

Yes 

No

No

Treatment duration 

Procedure followed by long-term follow-up 

Often requires ongoing treatment 

Often requires ongoing treatment  

Weight regain 

Possible 

Possible, particularly after stopping treatment 

Possible, particularly after stopping treatment 

Recovery 

Requires recovery 

No surgical recovery 

No surgical recovery 

Best suited for 

Depends on BMI, health conditions and surgical eligibility 

Depends on medical suitability and treatment indication 

Depends on medical suitability and treatment indication 

 

Which Offers Better Long-Term Weight Loss? 

Bariatric surgery can produce substantial and durable weight loss, while newer medicines such as semaglutide and Tirzepatide can also produce significant weight reduction in eligible patients. However, direct long-term comparisons between bariatric surgery and these newer medicines remain limited.

Clinical results also vary between individuals. Factors such as starting BMI, existing medical conditions, treatment response, lifestyle, adherence and long-term follow-up can influence outcomes.

Key considerations include:

  • Weight loss surgery can provide substantial and sustained weight loss in eligible patients.
  • Tirzepatide (Mounjaro) has shown greater average weight loss than semaglutide (Ozempic) in clinical studies.
  • Semaglutide (Ozempic) can support meaningful weight loss in medically appropriate patients.
  • Weight regain may occur after stopping weight loss injections or following bariatric surgery.
  • Long-term weight management, healthy lifestyle changes and medical follow-up are important.
  • The right weight loss treatment in Dubai depends on BMI, health conditions, treatment goals and individual response.

How to Choose the Right Weight Loss Treatment 

The right weight loss treatment depends on your BMI, overall health, weight-loss goals, previous treatment response, and whether you prefer a surgical or non-surgical approach.

Consider these factors:

  • BMI and obesity severity: May help determine whether surgery or medication is appropriate.
  • Existing health conditions: Diabetes, high blood pressure, sleep apnoea, and other conditions may influence treatment selection.
  • Expected weight loss: Discuss the amount of weight loss you may realistically achieve with each option.
  • Treatment preference: Consider whether you prefer medication or are open to surgery.
  • Long-term commitment: Both approaches require healthy lifestyle habits and medical follow-up.
  • Medical assessment: A bariatric specialist can evaluate your health and recommend an appropriate treatment plan.

Why Choose Dr. Girish Juneja for Weight Loss in Dubai?

Choosing the right bariatric surgeon is an important step when considering weight loss surgery. Dr. Girish Juneja combines extensive surgical experience, advanced bariatric expertise and personalised care to help patients explore suitable weight loss treatment options in Dubai.

Key reasons patients choose Dr. Girish Juneja include:

  • 30+ years of surgical experience across leading institutions in the UK, India and the UAE.
  • 1,000+ bariatric procedures performed, including primary laparoscopic and complex revision surgeries.
  • FASMBS fellowship, reflecting advanced training in metabolic and bariatric surgery.
  • IFSO membership, supporting continued engagement with developments in obesity and metabolic surgery.
  • Advanced minimally invasive techniques, including robotic-assisted surgery, magnetic technology and single-fire stapling where clinically appropriate.
  • Personalised treatment planning based on each patient’s health, BMI, weight-loss goals and medical needs.
  • International patient care, with patients travelling from the GCC, South Asia, Europe and other regions for bariatric treatment in Dubai.

Start Your Weight Loss Journey in Dubai

Choosing between weight loss surgery, Ozempic, Mounjaro, or other obesity treatment options depends on your BMI, medical history, weight-loss goals and overall health. There is no single approach that suits everyone.

If you are considering weight loss treatment in Dubai, a consultation with an experienced bariatric specialist can help you understand your options, potential benefits and risks, and the long-term commitment involved. Dr. Girish Juneja provides personalised bariatric care to help suitable patients work towards sustainable weight loss and improved health.

Book a consultation with Dr. Girish Juneja in Dubai to discuss your weight-loss goals and explore the treatment options suited to your needs.

Medical References & Publications

  • Dubai Health Authority. Standards for Bariatric Surgery Services – Version 2. 2023.
  • American Society for Metabolic and Bariatric Surgery (ASMBS) & International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). 2022 Indications for Metabolic and Bariatric Surgery.
  • American Society for Metabolic and Bariatric Surgery. Bariatric Surgery Procedures.

Frequently Asked Questions (FAQs)

Both procedures can produce substantial weight loss. Published outcomes vary, and individual results depend on starting weight, health conditions, diet, physical activity and long-term follow-up.

Both sleeve and bypass can improve type 2 diabetes. Gastric bypass can have a strong metabolic effect and may be considered for patients with poorly controlled type 2 diabetes.

Yes. Sleeve surgery can worsen reflux in some patients. If you already have significant GERD, your surgeon may discuss whether bypass is more appropriate.

The cost varies between hospitals and depends on the procedure and package inclusions. Your final quotation should be confirmed after consultation and assessment.

You can book an appointment with a qualified bariatric surgeon for an assessment of your BMI, medical history, weight-loss goals and suitability for sleeve or bypass surgery.